Interestingly, one of the pathways capable of upregulating CD73 in the absence of hypoxia is the WNT/β-catenin signaling pathway, which has recently been found to mediate T-cell exclusion and resistance to ICI therapy in a mouse model of melanoma [53]. This evidence concerns the gene NT5E and melanoma.